Last update:

Oncology & Cancer news

Oncology & Cancer

Genetic clues link lipoprotein A to prostate cancer risk

A new analysis has uncovered a potential link between higher prostate cancer risk and genetic variants associated with higher bloodstream levels of the cholesterol-transporting molecule lipoprotein A. Anna Ioannidou of Imperial ...

Oncology & Cancer

Tumors dramatically shrink with new approach to cell therapy

Northwestern University scientists have developed a new tool to harness immune cells from tumors to fight cancer rapidly and effectively.

Oncology & Cancer

Pancreatic cancer cells shown to feed on hyaluronic acid

Hyaluronic acid, or HA, is a known presence in pancreatic tumors, but a new study from researchers at the University of Michigan Health Rogel Cancer Center shows that hyaluronic acid also acts as food to the cancer cells. ...

Medications

Scientists find link between antibiotics and colon cancer

Scientists from the University of Aberdeen, NHS Grampian and Queen's University Belfast have found that antibiotic use may increase the risk of developing colon cancer, potentially more so among younger people.

Oncology & Cancer

New therapeutic target for hematologic malignancies identified

Inhibition of Ubiquitin Specific Peptidase 47 (USP47) was identified as a novel therapeutic target for hematologic malignancies bearing mutant oncoprotein EZH2, according to scientists from the Hefei Institutes of Physical ...

Oncology & Cancer

Players needed to solve puzzles and help advance cancer research

Scientists in Barcelona have today launched GENIGMA, a videogame that enlists players to solve puzzles while generating real-world scientific data that can detect alterations in genomic sequences and ultimately advance breast ...

Oncology & Cancer

Study finds cancer immunotherapy treatment can reverse HIV latency

An international research collaboration has found the cancer immunotherapy treatment, pembrolizumab, can reverse HIV latency, the ability for the virus to 'hide' inside cells of people living with HIV on antiretroviral therapy, ...

Oncology & Cancer

Faulty BRCA genes linked to prostate and pancreatic cancers

Faulty versions of the BRCA1 and BRCA2 genes are well known to increase the risk of breast cancer in men and women, and in ovarian cancer. Now BRCA1 and BRCA2 have been linked to several other cancers, including those that ...

Oncology & Cancer

Risk for cancer increased after VTE for patients with psoriasis

(HealthDay)—For patients with psoriasis, the risk for cancer is increased at the time of or after venous thromboembolism (VTE), according to a research letter published online Jan. 18 in the British Journal of Dermatology.

Medications

Combo immunotherapy ups survival in advanced liver cancer

(HealthDay)—STRIDE (Single tremelimumab Regular Interval durvalumab) is proposed as first-line therapy for unresectable hepatocellular carcinoma (uHCC), according to a study presented at the annual American Society of Clinical ...

Oncology & Cancer

Lung cancer: It is about more than smoking

World Cancer Day is February 4 and that makes this the ideal time to talk about lung cancer and smoking. Internationally, lung cancer is the most common cause of cancer deaths and the World Health Organization estimates that ...

Oncology & Cancer

Personalized cancer screening with AI

While mammograms are currently the gold standard in breast cancer screening, swirls of controversy exist: advocates argue for the ability to save lives, (women aged 60 to 69 had a 33 percent lower risk of dying compared to ...

Oncology & Cancer

Preclinical model may shed light on eye disease

Researchers at Weill Cornell Medicine have developed a preclinical model of the leading cause of central vision loss in older individuals and used it to identify new treatment modalities and drug targets.

Oncology & Cancer

Engineers given a role in making medical diagnoses

Engineers will play a bigger role in the healthcare system over the next ten years and thus also in cancer treatment. This is the opinion of Professor Thomas L. Andresen, former head of department at DTU Health Tech and now ...